These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15632293

  • 21. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
    Abidi P, Zhang F, Li C, Liu J.
    Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244
    [Abstract] [Full Text] [Related]

  • 22. The role of scaffold proteins in MEK/ERK signalling.
    Sacks DB.
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):833-6. PubMed ID: 17052209
    [Abstract] [Full Text] [Related]

  • 23. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
    Miranda MB, Xu H, Torchia JA, Johnson DE.
    Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
    [Abstract] [Full Text] [Related]

  • 24. NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade.
    Hematulin A, Sagan D, Eckardt-Schupp F, Moertl S.
    Cell Signal; 2008 Dec; 20(12):2276-85. PubMed ID: 18793719
    [Abstract] [Full Text] [Related]

  • 25. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM, Dong S, Fan M, Li JJ.
    Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
    [Abstract] [Full Text] [Related]

  • 26. Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-kappaB-dependent cell survival after serotonin 1A receptor activation.
    Hsiung SC, Tamir H, Franke TF, Liu KP.
    J Neurochem; 2005 Dec; 95(6):1653-66. PubMed ID: 16238696
    [Abstract] [Full Text] [Related]

  • 27. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation.
    Kim SE, Choi KY.
    Cell Signal; 2007 Jul; 19(7):1554-64. PubMed ID: 17374561
    [Abstract] [Full Text] [Related]

  • 28. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M.
    Biochem Biophys Res Commun; 2006 Nov 17; 350(2):450-6. PubMed ID: 17010316
    [Abstract] [Full Text] [Related]

  • 29. MEK-ERK signaling plays diverse roles in the regulation of facial chondrogenesis.
    Bobick BE, Kulyk WM.
    Exp Cell Res; 2006 Apr 15; 312(7):1079-92. PubMed ID: 16457813
    [Abstract] [Full Text] [Related]

  • 30. Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes.
    Casar B, Pinto A, Crespo P.
    Mol Cell; 2008 Sep 05; 31(5):708-21. PubMed ID: 18775330
    [Abstract] [Full Text] [Related]

  • 31. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W.
    J Cell Physiol; 2009 Jul 05; 220(1):214-21. PubMed ID: 19288493
    [Abstract] [Full Text] [Related]

  • 32. ERK activation and nuclear signaling induced by the loss of cell/matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells.
    Al-Ayoubi A, Tarcsafalvi A, Zheng H, Sakati W, Eblen ST.
    J Cell Biochem; 2008 Oct 15; 105(3):875-84. PubMed ID: 18726893
    [Abstract] [Full Text] [Related]

  • 33. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
    Ding W, Shi W, Bellusci S, Groffen J, Heisterkamp N, Minoo P, Warburton D.
    J Cell Physiol; 2007 Sep 15; 212(3):796-806. PubMed ID: 17516543
    [Abstract] [Full Text] [Related]

  • 34. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C.
    Cancer Res; 2006 Dec 15; 66(24):11851-8. PubMed ID: 17178882
    [Abstract] [Full Text] [Related]

  • 35. MEK partner 1 (MP1): regulation of oligomerization in MAP kinase signaling.
    Sharma C, Vomastek T, Tarcsafalvi A, Catling AD, Schaeffer HJ, Eblen ST, Weber MJ.
    J Cell Biochem; 2005 Mar 01; 94(4):708-19. PubMed ID: 15547943
    [Abstract] [Full Text] [Related]

  • 36. The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies.
    Calvo F, Agudo-Ibáñez L, Crespo P.
    Bioessays; 2010 May 01; 32(5):412-21. PubMed ID: 20414899
    [Abstract] [Full Text] [Related]

  • 37. Targeting Raf/MEK/ERK pathway in pituitary adenomas.
    Suojun Z, Feng W, Dongsheng G, Ting L.
    Eur J Cancer; 2012 Feb 01; 48(3):389-95. PubMed ID: 22119203
    [Abstract] [Full Text] [Related]

  • 38. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling.
    Pouysségur J, Volmat V, Lenormand P.
    Biochem Pharmacol; 2002 Sep 01; 64(5-6):755-63. PubMed ID: 12213567
    [Abstract] [Full Text] [Related]

  • 39. Regulation of isthmic Fgf8 signal by sprouty2.
    Suzuki-Hirano A, Sato T, Nakamura H.
    Development; 2005 Jan 01; 132(2):257-65. PubMed ID: 15590739
    [Abstract] [Full Text] [Related]

  • 40. ERK regulates strain-induced migration and proliferation from different subcellular locations.
    Gayer CP, Craig DH, Flanigan TL, Reed TD, Cress DE, Basson MD.
    J Cell Biochem; 2010 Mar 01; 109(4):711-25. PubMed ID: 20069571
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.